BMPs: From bone to body morphogenetic proteins

Science Signaling

Volumn 3, Issue 107, 2010, Pages

  Wagner, Darja Obradovic ^a   Sieber, Christina ^a   Bhushan, Raghu ^a   Börgermann, Jan H ^a   Graf, Daniel ^b   Knaus, Petra ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

BONE; BONE GROWTH; CONFERENCE PAPER; HOMEOSTASIS; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; BIOLOGICAL MODEL; BONE DEVELOPMENT; BRAIN; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY; METABOLISM; MORPHOGENESIS; PANCREAS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BONE AND BONES; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; BRAIN; GASTROINTESTINAL TRACT; HUMANS; KIDNEY; MODELS, BIOLOGICAL; MORPHOGENESIS; PANCREAS; SIGNAL TRANSDUCTION;

EID: 77951627143     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.3107mr1     Document Type: Conference Paper

References (56)

1. E. M. Horwitz, D. J. Prockop, L. A. Fitzpatrick, W. W. Koo, P. L. Gordon, M. Neel, M. Sussman, P. Orchard, J. C. Marx, R. E. Pyeritz, M. K. Brenner, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309-313 (1999).
2. S. D. Boden, J. Kang, H. Sandhu, J. G. Heller, Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: A prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27, 2662-2673 (2002).
3. D. Chen, M. Zhao, G. R. Mundy, Bone morphogenetic proteins. Growth Factors 22, 233-241 (2004).
4. A. H. Reddi, BMPs: From bone morphogenetic proteins to body morphogenetic proteins. Cytokine Growth Factor Rev. 16, 249-250 (2005).
5. K. Heinecke, A. Seher, W. Schmitz, T. D. Mueller, W. Sebald, J. Nickel, Receptor oligomerization and beyond: A case study in bone morphogenetic proteins. BMC Biol. 7, 59 (2009).
6. W. Sebald, J. Nickel, J. L. Zhang, T. D. Mueller, Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction. Biol. Chem. 385, 697-710 (2004).
7. C. De Bari, F. Dell'Accio, A. Karystinou, P. V. Guillot, N. M. Fisk, E. A. Jones, D. McGonagle, I. M. Khan, C. W. Archer, T. A. Mitsiadis, A. N. Donaldson, F. P. Luyten, C. Pitzalis, A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum. 58, 240-250 (2008).
8. C. De Bari, C. Pitzalis, F. Dell'Accio, Reparative medicine: From tissue engineering to joint surface regeneration. Regen. Med. 1, 59-69 (2006).
9. M. Blanco Calvo, V. Bolós Fernández, V. Medina Villaamil, G. Aparicio Gallego, S. Díaz Prado, E. Grande Pulido, Biology of BMP signalling and cancer. Clin. Transl. Oncol. 11, 126-137 (2009).
10. J. C. Hardwick, L. L. Kodach, G. J. Offerhaus, G. R. van den Brink, Bone morphogenetic protein signalling in colorectal cancer. Nat. Rev. Cancer 8, 806-812 (2008).
11. S. Steinert, T. C. Kroll, I. Taubert, L. Pusch, P. Hortschansky, K. Höffken, S. Wölfl, J. H. Clement, Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2. J. Cancer Res. Clin. Oncol. 134, 1237-1245 (2008).
12. Y. Park, M. H. Kang, H. Y. Seo, J. M. Park, C. W. Choi, Y. H. Kim, I. S. Kim, J. S. Kim, S. C. Oh, Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression. Med. Oncol., published online 19 November 2009 (PubMed ID: 19924575).
13. P. Seemann, A. Brehm, J. König, C. Reissner, S. Stricker, P. Kuss, J. Haupt, S. Renninger, J. Nickel, W. Sebald, J. C. Groppe, F. Plöger, J. Pohl, M. Schmidt-von Kegler, M. Walther, I. Gassner, C. Rusu, A. R. Janecke, K. Dathe, S. Mundlos, Mutations in GDF5 reveal a key residue mediating BMP inhibition by NOGGIN. PLoS Genet. Papers in Press, published 2009 as 10.1371/journal. pgen. 1000747.
14. K. Song, C. Krause, S. Shi, M. Patterson, R. K. Sutto, L. Grgurevic, S. Vukicevic, M. van Dinther, D. Falb, P. Ten Dijke, M. H. Alaoui-Ismaili, Identification of a key residue mediating bone morphogenetic protein (BMP) -6 resistance to noggin inhibition allows for engineered BMPs with superior-agonist activity. J. Biol. Chem., published online 4 January 2010 (PubMed ID: 20048150).
15. E. A. Bosman, K. A. Lawson, J. Debruyn, L. Beek, A. Francis, L. Schoonjans, D. Huylebroeck, A. Zwijsen, Smad5 determines murine amnion fate through the control of bone morphogenetic protein expression and signalling levels. Development 133, 3399-3409 (2006).
16. A. Nohe, S. Hassel, M. Ehrlich, F. Neubauer, W. Sebald, Y. I. Henis, P. Knaus, The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem. 277, 5330-5338 (2002).
17. R. Schwappacher, J. Weiske, E. Heining, V. Ezerski, B. Marom, Y. I. Henis, O. Huber, P. Knaus, Novel crosstalk to BMP signalling: cGMP-dependent kinase I modulates BMP receptor and Smad activity. EMBO J. 28, 1537-1550 (2009).
18. C. Sieber, J. Kopf, C. Hiepen, P. Knaus, Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 20, 343-355 (2009).
19. C. Gamell, N. Osses, R. Bartrons, T. Rückle, M. Camps, J. L. Rosa, F. Ventura, BMP2 induction of actin cytoskeleton reorganization and cell migration requires PI3-kinase and Cdc42 activity. J. Cell Sci. 121, 3960-3970 (2008).
20. A. Ulsamer, M. J. Ortuño, S. Ruiz, A. R. Susperregui, N. Osses, J. L. Rosa, F. Ventura, BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J. Biol. Chem. 283, 3816-3826 (2008).
21. J. L. Zhang, L. Y. Qiu, A. Kotzsch, S. Weidauer, L. Patterson, M. Hammerschmidt, W. Sebald, T. D. Mueller, Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev. Cell 14, 739-750 (2008).
22. E. M. De Robertis, Spemann's organizer and the self-regulation of embryonic fields. Mech. Dev. 126, 925-941 (2009).
23. J. Groppe, C. S. Hinck, P. Samavarchi-Tehrani, C. Zubieta, J. P. Schuermann, A. B. Taylor, P. M. Schwarz, J. L. Wrana, A. P. Hinck, Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Mol. Cell 29, 157-168 (2008).
24. G. P. Allendorph, W. W. Vale, S. Choe, Structure of the ternary signaling complex of a TGF-beta superfamily member. Proc. Natl. Acad. Sci. U. S. A. 103, 7643-7648 (2006).
25. P. B. Yu, C. C. Hong, C. Sachidanandan, J. L. Babitt, D. Y. Deng, S. A. Hoyng, H. Y. Lin, K. D. Bloch, R. T. Peterson, Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat. Chem. Biol. 4, 33-41 (2008).
26. S. G. C. Oxford Structures, No. 778, PDB code 3H9R (http://www.sgc.ox.ac. uk/structures/MM/XX01ACVR1A-3h9r-MM.html).
27. E. Seuntjens, A. Nityanandam, A. Miquelajauregui, J. Debruyn, A. Stryjewska, S. Goebbels, K. A. Nave, D. Huylebroeck, V. Tarabykin, Sip1 regulates sequential fate decisions by feedback signaling from postmitotic neurons to progenitors. Nat. Neurosci. 12, 1373-1380 (2009).
28. D. M. Valenzuela, A. J. Murphy, D. Frendewey, N. W. Gale, A. N. Economides, W. Auerbach, W. T. Poueymirou, N. C. Adams, J. Rojas, J. Yasenchak, R. Chernomorsky, M. Boucher, A. L. Elsasser, L. Esau, J. Zheng, J. A. Griffiths, X. Wang, H. Su, Y. Xue, M. G. Dominguez, I. Noguera, R. Torres, L. E. Macdonald, A. F. Stewart, T. M. DeChiara, G. D. Yancopoulos, High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat. Biotechnol. 21, 652-659 (2003).
29. T. M. DeChiara, W. T. Poueymirou, W. Auerbach, D. Frendewey, G. D. Yancopoulos, D. M. Valenzuela, VelociMouse: Fully ES cell-derived F0-generation mice obtained from the injection of ES cells into eight-cell-stage embryos. Methods Mol. Biol. 530, 311-324 (2009).
30. Regeneron (www.regeneron.com).
31. E. A. Lin, L. Kong, X. H. Bai, Y. Luan, C. J. Liu, miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. J. Biol. Chem. 284, 11326-11335 (2009).
32. Z. Li, M. Q. Hassan, S. Volinia, A. J. van Wijnen, J. L. Stein, C. M. Croce, J. B. Lian, G. S. Stein, A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. U. S. A. 105, 13906-13911 (2008).
33. B. N. Davis, A. C. Hilyard, G. Lagna, A. Hata, SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61 (2008).
34. DIANA-microT (http://diana.cslab.ece.ntua.gr/microT/).
35. M. Maragkakis, P. Alexiou, G. L. Papadopoulos, M. Reczko, T. Dalamagas, G. Giannopoulos, G. Goumas, E. Koukis, K. Kourtis, V. A. Simossis, P. Sethupathy, T. Vergoulis, N. Koziris, T. Sellis, P. Tsanakas, A. G. Hatzigeorgiou, Accurate micro-RNA target prediction correlates with protein repression levels. BMC Bioinformatics 10, 295 (2009).
36. DIANA-mirPath (http://diana.cslab.ece.ntua.gr/xpathways/).
37. G. L. Papadopoulos, P. Alexiou, M. Maragkakis, M. Reczko, A. G. Hatzigeorgiou, DIANA-mirPath: Integrating human and mouse microRNAs in pathways. Bioinformatics 25, 1991-1993 (2009).
38. DIANA-mirExTra (http://diana.cslab.ece.ntua.gr/hexamers/).
39. Y. Kawahara, B. Zinshteyn, P. Sethupathy, H. Iizasa, A. G. Hatzigeorgiou, K. Nishikura, Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 315, 1137-1140 (2007).
40. CARPET (http://host13.bioinfo3.ifom-ieocampus.it:8080).
41. S. Pregizer, D. P. Mortlock, Control of BMP gene expression by long-range regulatory elements. Cytokine Growth Factor Rev. 20, 509-515 (2009).
42. K. Dathe, K. W. Kjaer, A. Brehm, P. Meinecke, P. Nürnberg, J. C. Neto, D. Brunoni, N. Tommerup, C. E. Ott, E. Klopocki, P. Seemann, S. Mundlos, Duplications involving a conserved regulatory element downstream of BMP2 are associated with brachydactyly type A2. Am. J. Hum. Genet. 84, 483-492 (2009).
43. M. Cesaroni, D. Cittaro, A. Brozzi, P. G. Pelicci, L. Luzi, CARPET: A web-based package for the analysis of ChIP-chip and expression tiling data. Bioinformatics 24, 2918-2920 (2008).
44. BMPedia (http://wikis.fu-berlin. de/display/BIOCHEPHAKnaus/Main+Page).
45. B. Andriopoulos, Jr., E. Corradini, Y. Xia, S. A. Faasse, S. Chen, L. Grgurevic, M. D. Knutson, A. Pietrangelo, S. Vukicevic, H. Y. Lin, J. L. Babitt, BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 41, 482-487 (2009).
46. L. Konrad, J. A. Scheiber, M. Bergmann, O. Eickelberg, R. Hofmann, Identification of a new human Smad6 splice variant. Andrologia 40, 358-363 (2008).
47. O. Eickelberg, R. E. Morty, Transforming growth factor beta/bone morphogenic protein signaling in pulmonary arterial hypertension: Remodeling revisited. Trends Cardiovasc. Med. 17, 263-269 (2007).
48. T. Helbing, F. Volkmar, U. Goebel, J. Heinke, P. Diehl, H. L. Pahl, C. Bode, C. Patterson, M. Moser, Krüppel-like factor 15 regulates BMPER in endothelial cells. Cardiovasc. Res. 85, 551-559 (2010).
49. J. Heinke, L. Wehofsits, Q. Zhou, C. Zoeller, K. M. Baar, T. Helbing, A. Laib, H. Augustin, C. Bode, C. Patterson, M. Moser, BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ. Res. 103, 804-812 (2008).
50. L. David, C. Mallet, M. Keramidas, N. Lamandé, J. M. Gasc, S. Dupuis-Girod, H. Plauchu, J. J. Feige, S. Bailly, Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ. Res. 102, 914-922 (2008).
51. B. Herrera, G. J. Inman, A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol. 10, 20 (2009).
52. R. J. Lories, F. P. Luyten, Bone morphogenetic protein signaling in joint homeostasis and disease. Cytokine Growth Factor Rev. 16, 287-298 (2005).
53. S. Vukicevic, L. Grgurevic, BMP-6 and mesenchymal stem cell differentiation. Cytokine Growth Factor Rev. 20, 441-448 (2009).
54. R. E. Schreiber, K. Blease, A. Ambrosio, E. Amburn, B. Sosnowski, T. K. Sampath, Bone induction by AdBMP-2/collagen implants. J. Bone Joint Surg. Am. 87, 1059-1068 (2005).
55. P. Eliasson, A. Fahlgren, P. Aspenberg, Mechanical load and BMP signaling during tendon repair: A role for follistatin? Clin. Orthop. Relat. Res. 466, 1592-1597 (2008).
56. F. S. Kaplan, R. J. Pignolo, E. M. Shore, The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling. Cytokine Growth Factor Rev. 20, 399-407 (2009).